Soluble transferrin receptor for the evaluation of erythropoiesis and iron status

Clinica Chimica Acta

Volumn 329, Issue 1-2, 2003, Pages 9-22

  Beguin, Yves ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

Erythropoiesis; Iron deficiency; Transferrin receptor

Indexed keywords

BUTYRIC ACID; COBALAMIN; CYCLOSPORIN; FERRITIN; HEMOGLOBIN; IRON; THEOPHYLLINE; TRANSFERRIN RECEPTOR;

ANEMIA; BLOOD LEVEL; BONE MARROW TRANSPLANTATION; CHRONIC LYMPHATIC LEUKEMIA; ERYTHROBLAST; ERYTHROCYTOSIS; ERYTHROPOIESIS; HEMOLYSIS; HUMAN; INFLAMMATION; IRON DEFICIENCY; IRON DEFICIENCY ANEMIA; IRON TRANSPORT; LIVER CELL CARCINOMA; MEGALOBLASTIC ANEMIA; NONHODGKIN LYMPHOMA; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN STRUCTURE; RETICULOCYTE; REVIEW; THALASSEMIA;

ANIMALIA;

EID: 0037362778     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-8981(03)00005-6     Document Type: Review

References (136)

1. Shih Y.J., Baynes R.D., Hudson B.G., Flowers C.H., Skikne B.S., Cook J.D. Serum transferrin receptor is a truncated form of tissue receptor. J. Biol. Chem. 265:1990;19077-19081.
2. Johnstone R.M. The Jeanne Manery-Fisher Memorial Lecture 1991. Maturation of reticulocytes: formation of exosomes as a mechanism for shedding membrane proteins. Biochem. Cell. Biol. 70:1992;179-190.
3. Baynes R.D., Shih Y.J., Cook J.D. Mechanism of production of the serum transferrin receptor. Adv. Exp. Med. Biol. 356:1994;61-68.
4. R'Zik S., Loo M., Beguin Y. Reticulocyte transferrin receptor (TfR) expression and contribution to soluble TfR levels. Haematologica. 86:2001;244-251.
5. R'Zik S., Beguin Y. Serum soluble transferrin receptor concentration is an accurate estimate of the mass of tissue receptors. Exp. Hematol. 29:2001;677-685.
6. Kohgo Y., Nishisato T., Kondo H., Tsushima N., Niitsu Y., Urushizaki I. Circulating transferrin receptor in human serum. Br. J. Haematol. 64:1986;277-281.
7. Beguin Y., Huebers H.A., Josephson B., Finch C.A. Transferrin receptors in rat plasma. Proc. Natl. Acad. Sci. U. S. A. 85:1988;637-640.
8. Allen J., Backstrom K.R., Cooper J.A.et al. Measurement of soluble transferrin receptor in serum of healthy adults. Clin. Chem. 44:1998;35-39.
9. Virtanen M.A., Viinikka L.U., Virtanen M.K.et al. Higher concentrations of serum transferrin receptor in children than in adults. Am. J. Clin. Nutr. 69:1999;256-260.
10. Anttila R., Cook J.D., Siimes M.A. Body iron stores decrease in boys during pubertal development: the transferrin receptor-ferritin ratio as an indicator of iron status. Pediatr. Res. 41:1997;224-228.
11. Suominen P., Virtanen A., Lehtonen-Veromaa M.et al. Regression-based reference limits for serum transferrin receptor in children 6 months to 16 years of age. Clin. Chem. 47:2001;935-937.
12. Huebers H.A., Beguin Y., Pootrakul P., Einspahr D., Finch C.A. Intact transferrin receptors in human plasma and their relation to erythropoiesis. Blood. 75:1990;102-107.
13. Flowers C.H., Skikne B.S., Covell A.M., Cook J.D. The clinical measurement of serum transferrin receptor. J. Lab. Clin. Med. 114:1989;368-377.
14. Beguin Y., Oris R., Fillet G. Dynamics of erythropoietic recovery after bone marrow transplantation: role of marrow proliferative capacity and erythropoietin production in autologous versus allogeneic transplants. Bone Marrow Transplant. 11:1993;285-292.
15. Beguin Y., Clemons G., Pootrakul P., Fillet G. Quantitative assessment of erythropoiesis and functional classification of anemia based on measurements of serum transferrin receptor and erythropoietin. Blood. 81:1993;1067-1076.
16. Corazza F., Beguin Y., Bergmann P.et al. Anemia in children with cancer is associated with decreased erythropoietic activity and not with inadequate erythropoietin production. Blood. 92:1998;1793-1798.
17. Beguin Y., Lampertz S., Bron D., Fillet G. Serum erythropoietin in chronic lymphocytic leukemia. Br. J. Haematol. 93:1996;154-156.
18. Beguin Y., Yerna M., Loo M., Weber M., Fillet G. Erythropoiesis in multiple myeloma: defective red cell production due to inappropriate erythropoietin production. Br. J. Haematol. 82:1992;648-653.
19. Cazzola M., Ponchio L., de Benedetti F.et al. Defective iron supply for erythropoiesis and adequate endogenous erythropoietin production in the anemia associated with systemic-onset juvenile chronic arthritis. Blood. 87:1996;4824-4830.
20. Beguin Y., Baron F., Fillet G. Influence of marrow erythropoietic activity on serum erythropoietin levels after autologous hematopoietic stem cell transplantation. Haematologica. 83:1998;1076-1081.
21. Cazzola M., Guarnone R., Cerani P., Centenara E., Rovati A., Beguin Y. Red blood cell precursor mass as an independent determinant of serum erythropoietin level. Blood. 91:1998;2139-2145.
22. Cazzola M., Guarnone R., Cerani P., Rovati A., Ascari E. Congenital erythropoietin-dependent erythrocytosis responsive to theophylline treatment [letter; comment]. Blood. 91:1998;360-361.
23. Cappellini M.D., Graziadei G., Ciceri L.et al. Butyrate trials. Ann. N.Y. Acad. Sci. 850:1998;110-119.
24. Ledue T.B., Craig W.Y. Serum concentrations of transferrin receptor in hereditary hemochromatosis. Clin. Chem. 41:1995;1053-1054.
25. Schrezenmeier H., Noe G., Raghavachar A., Rich I.N., Heimpel H., Kubanek B. Serum erythropoietin and serum transferrin receptor levels in aplastic anaemia. Br. J. Haematol. 88:1994;286-294.
26. Beshara S., Birgegard G., Goch J., Wahlberg J., Wikstrom B., Danielson B.G. Assessment of erythropoiesis following renal transplantation. Eur. J. Haematol. 58:1997;167-173.
27. Singhal A., Cook J.D., Skikne B.S., Thomas P., Serjeant B., Serjeant G. The clinical significance of serum transferrin receptor levels in sickle cell disease. Br. J. Haematol. 84:1993;301-304.
28. El Nawawy A., Massoud M.N., El Bordiny M., Hegazy S. Evaluation of serum soluble transferrin receptors and erythropoietin levels as indicators for erythropoietic activity among multi-transfused beta-thalassemic patients. J. Trop. Pediatr. 48:2002;33-38.
29. Cazzola M., Borgna-Pignatti C., Locatelli F., Ponchio L., Beguin Y., De Stefano P. A moderate transfusion regimen may reduce iron loading in beta-thalassemia major without producing excessive expansion of erythropoiesis. Transfusion. 37:1997;135-140.
30. Tancabelic J., Sheth S., Paik M., Piomelli S. Serum transferrin receptor as a marker of erythropoiesis suppression in patients on chronic transfusion. Am. J. Hematol. 60:1999;121-125.
31. Loukopoulos D., Voskaridou E., Kalotychou V., Schina M., Loutradi A., Theodoropoulos I. Reduction of the clinical severity of sickle cell/beta-thalassemia with hydroxyurea: the experience of a single center in Greece. Blood Cells Mol. Dis. 26:2000;453-466.
32. Beguin Y., Loo M., R'Zik S.et al. Quantitative assessment of erythropoiesis in haemodialysis patients demonstrates gradual expansion of erythroblasts during constant treatment with recombinant human erythropoietin. Br. J. Haematol. 89:1995;17-23.
33. Beguin Y., Loo M., R'Zik S.et al. Early prediction of response to recombinant human erythropoietin in patients with the anemia of renal failure by serum transferrin receptor and fibrinogen. Blood. 82:1993;2010-2016.
34. Bessho M., Hirashima K., Asano S.et al. Treatment of the anemia of aplastic anemia patients with recombinant human erythropoietin in combination with granulocyte colony-stimulating factor: a multicenter randomized controlled study. Multicenter Study Group. Eur. J. Haematol. 58:1997;265-272.
35. Martelli M., Ponchio L., Beguin Y., Meloni G., Mandelli F., Cazzola M. Pure red cell aplasia following peripheral stem cell transplantation: complete response to a short course of high-dose recombinant human erythropoietin. Haematologica. 79:1994;456-459.
36. Dore F., Bonfigli S., Gaviano E., Pardini S., Longinotti M. Serum transferrin receptor levels in patients with thalassemia intermedia during rHuEPO administration. Haematologica. 81:1996;37-39.
37. Cazzola M., Ponchio L., Beguin Y.et al. Subcutaneous erythropoietin for treatment of refractory anemia in hematologic disorders. Results of a phase I/II clinical trial. Blood. 79:1992;29-37.
38. Cazzola M., Ponchio L., Pedrotti C.et al. Prediction of response to recombinant human erythropoietin (rHuEpo) in anemia of malignancy. Haematologica. 81:1996;434-441.
39. Ludwig H., Fritz E., Leitgeb C., Pecherstorfer M., Samonigg L., Schuster J. Prediction of response to erythropoietin treatment in chronic anemia of cancer. Blood. 84:1994;1056-1063.
40. Hellstrom-Lindberg E., Ahlgren T., Beguin Y.et al. Treatment of anemia in myelodysplastic syndromes with granulocyte colony-stimulating factor plus erythropoietin: results from a randomized phase II study and long-term follow-up of 71 patients. Blood. 92:1998;68-75.
41. Pettersson T., Teppo A.M., Siimes M.A. Circulating transferrin receptor during erythropoietin medication of anemic patients with rheumatoid arthritis. Scand. J. Rheumatol. 25:1996;321-324.
42. Eschbach J.W., Haley N.R., Egrie J.C., Adamson J.W. A comparison of the responses to recombinant human erythropoietin in normal and uremic subjects. Kidney Int. 42:1992;407-416.
43. van Iperen C.E., Gaillard C.A., Kraaijenhagen R.J., Braam B.G., Marx J.J., van de W.A. Response of erythropoiesis and iron metabolism to recombinant human erythropoietin in intensive care unit patients. Crit. Care Med. 28:2000;2773-2778.
44. Gareau R., Audran M., Baynes R.D.et al. Erythropoietin abuse in athletes [letter]. Nature. 380:1996;113.
45. Biesma D.H., van de Wiel A., Beguin Y., Kraaijenhagen R.J., Marx J.J. Erythropoietic activity and iron metabolism in autologous blood donors during recombinant human erythropoietin therapy. Eur. J. Clin. Invest. 24:1994;426-432.
46. Krallis N., Cholevas V., Mavridis A., Georgiou I., Bourantas K., Andronikou S. Effect of recombinant human erythropoietin in preterm infants. Eur. J. Haematol. 63:1999;71-76.
47. Locatelli F., Zecca M., Beguin Y.et al. Accelerated erythroid repopulation with no stem-cell competition effect in children treated with recombinant human erythropoietin after allogeneic bone marrow transplantation. Br. J. Haematol. 84:1993;752-754.
48. Baron F., Sautois B., Baudoux E., Matus G., Fillet G., Beguin Y. Optimization of recombinant human erythropoietin therapy after allogeneic hematopoietic stem cell transplantation. Exp. Hematol. 30:2002;546-554.
49. Piron M., Loo M., Gothot A., Tassin F., Fillet G., Beguin Y. Cessation of intensive treatment with recombinant human erythropoietin is followed by secondary anemia. Blood. 97:2001;442-448.
50. Magnani M., Corsi D., Bianchi M.et al. Identification of blood erythroid markers useful in revealing erythropoietin abuse in athletes. Blood Cells Mol. Dis. 27:2001;559-571.
51. Parisotto R., Gore C.J., Emslie K.R.et al. A novel method utilising markers of altered erythropoiesis for the detection of recombinant human erythropoietin abuse in athletes. Haematologica. 85:2000;564-572.
52. Koistinen P.O., Rusko H., Irjala K.et al. EPO, red cells, and serum transferrin receptor in continuous and intermittent hypoxia. Med. Sci. Sports Exerc. 32:2000;800-804.
53. Stray-Gundersen J., Chapman R.F., Levine B.D. "Living high-training low" altitude training improves sea level performance in male and female elite runners. J. Appl. Physiol. 91:2001;1113-1120.
54. A randomized double-blind placebo-controlled study with subcutaneous recombinant human erythropoietin in patients with low-risk myelodysplastic syndromes. Italian Cooperative Study Group for rHuEpo in Myelodysplastic Syndromes. Br J Haematol 1998;103:1070-4.
55. Kim S.W., Luykx D.M., de Vries S., Duine J.A. A second molybdoprotein aldehyde dehydrogenase from Amycolatopsis methanolica NCIB 11946. Arch. Biochem. Biophys. 325:1996;1-7.
56. Thorstensen K., Romslo I. Measurement of serum transferrin receptors in screening for hemochromatosis. Clin. Chem. 38:1992;1510.
57. Baynes R.D., Cook J.D., Bothwell T.H., Friedman B.M., Meyer T.E. Serum transferrin receptor in hereditary hemochromatosis and African siderosis. Am. J. Hematol. 45:1994;288-292.
58. Khumalo H., Gomo Z.A., Moyo V.M.et al. Serum transferrin receptors are decreased in the presence of iron overload. Clin. Chem. 44:1998;40-44.
59. Akesson A., Bjellerup P., Vahter M. Evaluation of kits for measurement of the soluble transferrin receptor. Scand. J. Clin. Lab. Invest. 59:1999;77-81.
60. Ahluwalia N. Diagnostic utility of serum transferrin receptors measurement in assessing iron status. Nutr. Rev. 56:1998;133-141.
61. Punnonen K., Irjala K., Rajamaki A. Serum transferrin receptor and its ratio to serum ferritin in the diagnosis of iron deficiency. Blood. 89:1997;1052-1057.
62. Olivares M., Walter T., Cook J.D., Hertrampf E., Pizarro F. Usefulness of serum transferrin receptor and serum ferritin in diagnosis of iron deficiency in infancy. Am. J. Clin. Nutr. 72:2000;1191-1195.
63. Kotisaari S., Romppanen J., Penttila I., Punnonen K. The Advia 120 red blood cells and reticulocyte indices are useful in diagnosis of iron-deficiency anemia. Eur. J. Haematol. 68:2002;150-156.
64. Choi J.W., Pai S.H. Reticulocyte subpopulations and reticulocyte maturity index (RMI) rise as body iron status falls. Am. J. Hematol. 67:2001;130-135.
65. Mast A.E., Blinder M.A., Gronowski A.M., Chumley C., Scott M.G. Clinical utility of the soluble transferrin receptor and comparison with serum ferritin in several populations. Clin. Chem. 44:1998;45-51.
66. Niinikoski H., Koskinen P., Punnonen K.et al. Intake and indicators of iron and zinc status in children consuming diets low in saturated fat and cholesterol: the STRIP baby study. Special Turku Coronary Risk Factor Intervention Project for Babies. Am. J. Clin. Nutr. 66:1997;569-574.
67. Skikne B.S., Flowers C.H., Cook J.D. Serum transferrin receptor: a quantitative measure of tissue iron deficiency. Blood. 75:1990;1870-1876.
68. Malope B.I., MacPhail A.P., Alberts M., Hiss D.C. The ratio of serum transferrin receptor and serum ferritin in the diagnosis of iron status. Br. J. Haematol. 115:2001;84-89.
69. Cermak J., Brabec V. Transferrin receptor-ferritin index: a useful parameter in differential diagnosis of iron deficiency and hyperplastic erythropoiesis. Eur. J. Haematol. 61:1998;210-212.
70. Gimferrer E., Ubeda J., Royo M.T.et al. Serum transferrin receptor levels in different stages of iron deficiency. Blood. 90:1997;1332-1334.
71. Brugnara C., Zurakowski D., DiCanzio J., Boyd T., Platt O. Reticulocyte hemoglobin content to diagnose iron deficiency in children. JAMA. 281:1999;2225-2230.
72. Harthoorn-Lasthuizen E.J., van't Sant P., Lindemans J., Langenhuijsen M.M. Serum transferrin receptor and erythrocyte zinc protoporphyrin in patients with anemia. Clin. Chem. 46:2000;719-722.
73. Kohgo Y., Niitsu Y., Kondo H.et al. Serum transferrin receptor as a new index of erythropoiesis. Blood. 70:1987;1955-1958.
74. Zhu Y.I., Haas J.D. Response of serum transferrin receptor to iron supplementation in iron-depleted, nonanemic women. Am. J. Clin. Nutr. 67:1998;271-275.
75. Brownlie T., Utermohlen V., Hinton P.S., Giordano C., Haas J.D. Marginal iron deficiency without anemia impairs aerobic adaptation among previously untrained women. Am. J. Clin. Nutr. 75:2002;734-742.
76. Martini A., Ravelli A., Di Fuccia G., Rosti V., Cazzola M., Barosi G. Intravenous iron therapy for severe anaemia in systemic-onset juvenile chronic arthritis. Lancet. 344:1994;1052-1054.
77. Suominen P., Punnonen K., Rajamaki A., Irjala K. Serum transferrin receptor and transferrin receptor-ferritin index identify healthy subjects with subclinical iron deficits. Blood. 92:1998;2934-2939.
78. Beguin Y., Grek V., Weber G.et al. Acute functional iron deficiency in obese subjects during a very-low-energy all-protein diet. Am. J. Clin. Nutr. 66:1997;75-79.
79. Asobayire F.S., Adou P., Davidsson L., Cook J.D., Hurrell R.F. Prevalence of iron deficiency with and without concurrent anemia in population groups with high prevalences of malaria and other infections: a study in Cote d'Ivoire. Am. J. Clin. Nutr. 74:2001;776-782.
80. Lammi-Keefe C.J., Lickteig E.S., Ahluwalia N., Haley N.R. Day-to-day variation in iron status indexes is similar for most measures in elderly women with and without rheumatoid arthritis. J. Am. Diet. Assoc. 96:1996;247-251.
81. Ferguson B.J., Skikne B.S., Simpson K.M., Baynes R.D., Cook J.D. Serum transferrin receptor distinguishes the anemia of chronic disease from iron deficiency anemia. J. Lab. Clin. Med. 119:1992;385-390.
82. Semba R.D., Kumwenda N., Hoover D.R.et al. Assessment of iron status using plasma transferrin receptor in pregnant women with and without human immunodeficiency virus infection in Malawi. Eur. J. Clin. Nutr. 54:2000;872-877.
83. Dimitriou H., Stiakaki E., Markaki E.A., Bolonaki I., Giannakopoulou C., Kalmanti M. Soluble transferrin receptor levels and soluble transferrin receptor/log ferritin index in the evaluation of erythropoietic status in childhood infections and malignancy. Acta Paediatr. 89:2000;1169-1173.
84. Wians F.H. Jr., Urban J.E., Keffer J.H., Kroft S.H. Discriminating between iron deficiency anemia and anemia of chronic disease using traditional indices of iron status vs. transferrin receptor concentration. Am. J. Clin. Pathol. 115:2001;112-118.
85. Reynolds P. Newborns have unique confounding factors regarding the TfR-F ratio. Arch. Dis. Child Fetal Neonatal Ed. 85:2001;F146.
86. Ho C.H. The differential diagnostic values of serum transferrin receptor, serum ferritin and related parameters in the patients with various causes of anemia. Haematologica. 86:2001;206-207.
87. Remacha A.F., Sarda M.P., Parellada M., Ubeda J., Manteiga R. The role of serum transferrin receptor in the diagnosis of iron deficiency. Haematologica. 83:1998;963-966.
88. Pettersson T., Kivivuori S.M., Siimes M.A. Is serum transferrin receptor useful for detecting iron-deficiency in anaemic patients with chronic inflammatory diseases? Br. J. Rheumatol. 33:1994;740-744.
89. Suominen P., Punnonen K., Rajamaki A., Irjala K. Evaluation of new immunoenzymometric assay for measuring soluble transferrin receptor to detect iron deficiency in anemic patients. Clin. Chem. 43:1997;1641-1646.
90. Suominen P., Mottonen T., Rajamaki A., Irjala K. Single values of serum transferrin receptor and transferrin receptor ferritin index can be used to detect true and functional iron deficiency in rheumatoid arthritis patients with anemia. Arthritis Rheum. 43:2000;1016-1020.
91. Rimon E., Levy S., Sapir A.et al. Diagnosis of iron deficiency anemia in the elderly by transferrin receptor-ferritin index. Arch. Intern. Med. 162:2002;445-449.
92. Zoli A., Altomonte L., Mirone L.et al. Serum transferrin receptors in rheumatoid arthritis. Ann. Rheum. Dis. 53:1994;699-701.
93. Nielsen O.J., Andersen L.S., Hansen N.E., Hansen T.M. Serum transferrin receptor levels in anaemic patients with rheumatoid arthritis. Scand. J. Clin. Lab. Invest. 54:1994;75-82.
94. Revel-Vilk S., Tamary H., Broide E.et al. Serum transferrin receptor in children and adolescents with inflammatory bowel disease. Eur. J. Pediatr. 159:2000;585-589.
95. Junca J., Fernandez-Aviles F., Oriol A.et al. The usefulness of the serum transferrin receptor in detecting iron deficiency in the anemia of chronic disorders. Haematologica. 83:1998;676-680.
96. Noe G., Augustin J., Hausdorf S., Rich I.N., Kubanek B. Serum erythropoietin and transferrin receptor levels in patients with rheumatoid arthritis. Clin. Exp. Rheumatol. 13:1995;445-451.
97. Baumann Kurer S., Seifert B., Michel B., Ruegg R., Fehr J. Prediction of iron deficiency in chronic inflammatory rheumatic disease anaemia. Br. J. Haematol. 91:1995;820-826.
98. Feelders R.A., Vreugdenhil G., Manger B., van Eijk H.G., Swaak A.J. Serum transferrin receptor levels in anaemia of rheumatoid arthritis and effects of iron chelation treatment [letter]. Eur. J. Haematol. 52:1994;61-62.
99. Woith W., Nusslein I., Antoni C.et al. A soluble form of the human transferrin receptor is released by activated lymphocytes in vitro. Clin. Exp. Immunol. 92:1993;537-542.
100. Keevil B., Rowlands D., Burton I., Webb A.K. Assessment of iron status in cystic fibrosis patients. Ann. Clin. Biochem. 37(Pt. 5):2000;662-665.
101. Song J.S., Park W., Bae S.K.et al. The usefulness of serum transferrin receptor and ferritin for assessing anemia in rheumatoid arthritis: comparison with bone marrow iron study. Rheumatol. Int. 21:2001;24-29.
102. van Tellingen A., Kuenen J.C., de Kieviet W., van Tinteren H., Kooi M.L., Vasmel W.L. Iron deficiency anaemia in hospitalised patients: value of various laboratory parameters. Differentiation between IDA and ACD. Neth. J. Med. 59:2001;270-279.
103. Bultink I.E., Lems W.F., van de Stadt R.J.et al. Ferritin and serum transferrin receptor predict iron deficiency in anemic patients with rheumatoid arthritis. Arthritis Rheum. 44:2001;979-981.
104. Ahluwalia N., Lammi-Keefe C.J., Bendel R.B., Morse E.E., Beard J.L., Haley N.R. Iron deficiency and anemia of chronic disease in elderly women: a discriminant-analysis approach for differentiation. Am. J. Clin. Nutr. 61:1995;590-596.
105. Kivivuori S.M., Anttila R., Viinikka L., Pesonen K., Siimes M.A. Serum transferrin receptor for assessment of iron status in healthy prepubertal and early pubertal boys. Pediatr. Res. 34:1993;297-299.
106. Carpani G., Buscaglia M., Ghisoni L.et al. Soluble transferrin receptor in the study of fetal erythropoietic activity. Am. J. Hematol. 52:1996;192-196.
107. Kling P.J., Roberts R.A., Widness J.A. Plasma transferrin receptor levels and indices of erythropoiesis and iron status in healthy term infants. J. Pediatr. Hematol. Oncol. 20:1998;309-314.
108. Means R.T. Jr., Allen J., Sears D.A., Schuster S.J. Serum soluble transferrin receptor and the prediction of marrow aspirate iron results in a heterogeneous group of patients. Clin. Lab. Haematol. 21:1999;161-167.
109. Nagral A., Mehta A.B., Gomes A.T.et al. Serum soluble transferrin receptor in the diagnosis of iron deficiency in chronic liver disease. Clin. Lab. Haematol. 21:1999;93-97.
110. Fernandez-Rodriguez A.M., Guindeo-Casasus M.C., Molero-Labarta T.et al. Diagnosis of iron deficiency in chronic renal failure. Am. J. Kidney Dis. 34:1999;508-513.
111. Williams T.N., Maitland K., Rees D.C.et al. Reduced soluble transferrin receptor concentrations in acute malaria in Vanuatu. Am. J. Trop. Med. Hyg. 60:1999;875-878.
112. Beesley R., Filteau S., Tomkins A.et al. Impact of acute malaria on plasma concentrations of transferrin receptors. Trans. R. Soc. Trop. Med. Hyg. 94:2000;295-298.
113. Menendez C., Quinto L.L., Kahigwa E.et al. Effect of malaria on soluble transferrin receptor levels in Tanzanian infants. Am. J. Trop. Med. Hyg. 65:2001;138-142.
114. Mockenhaupt F.P., May U., Stark K., Falusi A.G., Meyer C.G., Bienzle U. Serum transferrin receptor levels are increased in asymptomatic and mild plasmodium falciparum-infection. Haematologica. 84:1999;869-873.
115. Stoltzfus R.J., Chwaya H.M., Montresor A., Albonico M., Savioli L., Tielsch J.M. Malaria, hookworms and recent fever are related to anemia and iron status indicators in 0- to 5-y old Zanzibari children and these relationships change with age. J. Nutr. 130:2000;1724-1733.
116. Kuvibidila S., Mark J.A., Warrier R.P., Yu L., Ode D., Tshefu K.A. Soluble transferrin receptor as an index of iron status in Zaïrian children with malaria. J. Trop. Med. Hyg. 98:1995;373-378.
117. Kivibidila S., Warrier R.P., Ode D., Yu L., Tshefu K.A. Lack of difference in iron status assessed by soluble transferrin receptor between children with cerebral malaria and those with non-cerebral malaria. J. Trop. Pediatr. 45:1999;166-167.
118. Ahluwalia N., Skikne B.S., Savin V., Chonko A. Markers of masked iron deficiency and effectiveness of EPO therapy in chronic renal failure. Am. J. Kidney Dis. 30:1997;532-541.
119. Lorenzo J.D., Rodriguez M.M., Martin S.S., Romo J.M. Assessment of erythropoiesis activity during hemodialysis therapy by soluble transferrin receptor levels and ferrokinetic measurements. Am. J. Kidney Dis. 37:2001;550-556.
120. Tessitore N., Solero G.P., Lippi G.et al. The role of iron status markers in predicting response to intravenous iron in haemodialysis patients on maintenance erythropoietin. Nephrol. Dial. Transplant. 16:2001;1416-1423.
121. Loo M., Beguin Y. The effect of recombinant human erythropoietin on platelet counts is strongly modulated by the adequacy of iron supply. Blood. 93:1999;3286-3293.
122. Beguin Y., Lipscei G., Thoumsin H., Fillet G. Blunted erythropoietin production and decreased erythropoiesis in early pregnancy. Blood. 78:1991;89-93.
123. Akesson A., Bjellerup P., Berglund M., Bremme K., Vahter M. Serum transferrin receptor: a specific marker of iron deficiency in pregnancy. Am. J. Clin. Nutr. 68:1998;1241-1246.
124. Huddle J.M., Gibson R.S., Cullinan T.R. The impact of malarial infection and diet on the anaemia status of rural pregnant Malawian women. Eur. J. Clin. Nutr. 53:1999;792-801.
125. Choi J.W., Pai S.H. Change in erythropoiesis with gestational age during pregnancy. Ann. Hematol. 80:2001;26-31.
126. Choi J.W., Im M.W., Pai S.H. Serum transferrin receptor concentrations during normal pregnancy. Clin. Chem. 46:2000;725-727.
127. Kuvibidila S., Yu L.C., Ode D.L., Warrier R.P., Mbele V. Assessment of iron status of Zairean women of childbearing age by serum transferrin receptor. Am. J. Clin. Nutr. 60:1994;603-609.
128. Rusia U., Flowers C., Madan N., Agarwal N., Sood S.K., Sikka M. Serum transferrin receptors in detection of iron deficiency in pregnancy. Ann. Hematol. 78:1999;358-363.
129. van den Broek N.R., Letsky E.A., White S.A., Shenkin A. Iron status in pregnant women: which measurements are valid? Br. J. Haematol. 103:1998;817-824.
130. Klemow D., Einsphar D., Brown T.A., Flowers C.H., Skikne B.S. Serum transferrin receptor measurements in hematologic malignancies. Am. J. Hematol. 34:1990;193-198.
131. Brada S.J., de Wolf J.T., Hendriks D., Louwes H., van den B.E., Vellenga E. Characterization of the erythropoiesis in myelodysplasia by means of ferrokinetic studies, in vitro erythroid colony formation and soluble transferrin receptor. Leukemia. 12:1998;340-345.
132. Bowen D.T., Culligan D., Beguin Y., Kendall R., Willis N. Estimation of effective and total erythropoiesis in myelodysplasia using serum transferrin receptor and erythropoietin concentrations, with automated reticulocyte parameters. Leukemia. 8:1994;151-155.
133. Dowlati A., Loo M., Bury T., Fillet G., Beguin Y. Soluble and cell-associated transferrin receptor in lung cancer. Br. J. Cancer. 75:1997;1802-1806.
134. Kohgo Y., Kondo H., Mogi Y., Niitsu Y. Mechanism and clinical significance of soluble hepatic cell-surface receptors. Targeted Diagn. Ther. 4:1991;305-319.
135. Takubo T., Kumura T., Nakao T.et al. Clinical usefulness of combined measurements of serum soluble transferrin receptor levels and serum interleukin-18 levels at determination of serum KL-6 levels in haematologic malignancies. Acta Haematol. 104:2000;141-143.
136. Stasi R., Zinzani L., Galieni P.et al. Clinical implications of cytokine and soluble receptor measurements in patients with newly-diagnosed aggressive non-Hodgkin's lymphoma. Eur. J. Haematol. 54:1995;9-17.